|
|
Volumn 99, Issue 4, 2007, Pages 530-534
|
|
Discontinuation of Lipid Modifying Drugs Among Commercially Insured United States Patients in Recent Clinical Practice
a
a
Merck
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
BILE ACID SEQUESTRANT;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NICOTINIC ACID;
ADULT;
AGED;
ARTICLE;
CLINICAL PRACTICE;
DATA BASE;
DRUG RESEARCH;
EXPIRATION DATE;
FEMALE;
HEALTH INSURANCE;
HUMAN;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
PRESCRIPTION;
PRIORITY JOURNAL;
TREATMENT WITHDRAWAL;
ADULT;
AGED;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
INSURANCE COVERAGE;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PROPORTIONAL HAZARDS MODELS;
RETROSPECTIVE STUDIES;
RISK REDUCTION BEHAVIOR;
UNITED STATES;
|
|
EID: 33846838863
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2006.08.063 Document Type: Article |
|
Times cited : (98)
|
|
References (4)
|
